Lee JL - Search Results

1

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.

Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain SA, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Bedke J, Gakis G, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Garcia Del Muro X, Rodriguez-Vida A, Cicin I, Harputluoglu H, Tagawa ST, Vaishampayan U, Aragon-Ching JB, Hamid O, Liepa AM, Wijayawardana S, Russo F, Walgren RA, Zimmermann AH, Hozak RR, Bell-McGuinn KM, Powles T; RANGE study investigators. Petrylak DP, et al. Among authors: lee jl. Lancet Oncol. 2020 Jan;21(1):105-120. doi: 10.1016/S1470-2045(19)30668-0. Epub 2019 Nov 18. Lancet Oncol. 2020. PMID: 31753727 Free PMC article. Clinical Trial.

2

Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma--a single institutional study.

Lee JL, Kim SB, Jung HY, Park SI, Kim DK, Kim JH, Song HY, Kim WK, Lee JS, Min YI. Lee JL, et al. Among authors: lee js. Acta Oncol. 2003;42(3):207-17. doi: 10.1080/02841860310010736. Acta Oncol. 2003. PMID: 12852697 Clinical Trial.

3

Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response.

Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Sohn HJ, Lee JS, Kang YK. Lee JL, et al. Among authors: lee js. Jpn J Clin Oncol. 2006 Nov;36(11):704-11. doi: 10.1093/jjco/hyl088. Epub 2006 Oct 26. Jpn J Clin Oncol. 2006. PMID: 17068083

4

Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.

Lee SS, Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Kim WK, Lee JS, Kang YK. Lee SS, et al. Among authors: lee js, lee jl. Jpn J Clin Oncol. 2007 Jan;37(1):30-7. doi: 10.1093/jjco/hyl134. Jpn J Clin Oncol. 2007. PMID: 17272321

5

A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.

Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Kim M, Chun YJ, Lee JS, Kang YK. Lee JL, et al. Among authors: lee js. Cancer Chemother Pharmacol. 2008 Apr;61(4):631-7. doi: 10.1007/s00280-007-0516-6. Epub 2007 May 23. Cancer Chemother Pharmacol. 2008. PMID: 17520252 Clinical Trial.

6

Extrapulmonary small cell carcinoma: single center experience with 61 patients.

Lee SS, Lee JL, Ryu MH, Chang HM, Kim TW, Kim WK, Lee JS, Jang SJ, Khang SK, Kang YK. Lee SS, et al. Among authors: lee js, lee jl. Acta Oncol. 2007;46(6):846-51. doi: 10.1080/02841860601071893. Acta Oncol. 2007. PMID: 17653910

7

Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.

Lee JL, Ryu MH, Chang HM, Kim TW, Lee SS, Sym SJ, Kim MK, Kim KM, Lee JS, Kang YK. Lee JL, et al. Among authors: lee js, lee ss. J Gastroenterol Hepatol. 2008 May;23(5):811-6. doi: 10.1111/j.1440-1746.2007.05213.x. Epub 2007 Nov 6. J Gastroenterol Hepatol. 2008. PMID: 17995941

8

Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.

Jo JC, Lee JL, Ryu MH, Sym SJ, Lee SS, Chang HM, Kim TW, Lee JS, Kang YK. Jo JC, et al. Among authors: lee js, lee ss, lee jl. Jpn J Clin Oncol. 2007 Dec;37(12):936-41. doi: 10.1093/jjco/hym123. Jpn J Clin Oncol. 2007. PMID: 18211985

9

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer.

Sym SJ, Chang HM, Kang HJ, Lee SS, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Sym SJ, et al. Among authors: lee ss, lee jl. Cancer Chemother Pharmacol. 2008 Dec;63(1):1-8. doi: 10.1007/s00280-008-0701-2. Epub 2008 Feb 21. Cancer Chemother Pharmacol. 2008. PMID: 18288477 Clinical Trial.

10

Salvage chemotherapy with biweekly irinotecan, plus 5-fluorouracil and leucovorin in patients with advanced gastric cancer previously treated with fluoropyrimidine, platinum, and taxane.

Sym SJ, Ryu MH, Lee JL, Chang HM, Kim TW, Lee SS, Lee JS, Kang YK. Sym SJ, et al. Among authors: lee js, lee ss, lee jl. Am J Clin Oncol. 2008 Apr;31(2):151-6. doi: 10.1097/COC.0b013e31815878a2. Am J Clin Oncol. 2008. PMID: 18391599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,114 results

Search Page

Filters